Brad Stone

Benaroya Research Inst At Virginia Mason

$1,449,950

Attributed

$1,449,950

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $521.6K · FY2007–09

$1M$750K$500K$250K$0

'07

'08

'09

Funding mix

By agency

NIH$1,449,950 · 3

By mechanism

R21$1,048,884 · 2

R01$401,066 · 1

Top collaborators

No co-investigators on record.

Most similar at Benaroya Research Inst At Virginia Mason

Same institution · by research overlap

Others in their field

Top investigators on “Prognostic”

Barton F Haynes · Duke University$107,675,530
Fred M Gordin · Social And Scientific Systems, Inc.$75,931,872
David Heimbrook · Leidos Biomedical Research, Inc.$63,777,541
David H Walker · University Of Texas Medical Br Galveston$61,066,312
Laurence H Baker · University Of Michigan At Ann Arbor$60,180,341
James D Crapo · University Of Colorado Denver$53,652,375

Research focus

PrognosticResponseHematologic NeoplasmsPlayAdverse EffectsProteinsEnzyme Linked Immunospot AssayGraft-Vs-Host DiseaseLeukemiaNovel TherapeuticsAntigen TargetingAutoimmune ProcessAllogenicGenetic Screening MethodAcute Graft Versus Host DiseaseDesignDiagnosisGenotypeHematopoieticEpitopesMinorMinor Histocompatibility AntigensCell TransplantationT-Lymphocyte

Grant awards (5)

Novel Minor Histocompatibility Antigens Determined by Coding Deletion Polymorphis$228,750

R21 · FY2009 · AI · contact PI

Novel Minor Histocompatibility Antigens Determined by Coding Deletion Polymorphis$287,221

R21 · FY2008 · AI · contact PI

A novel method for identification of minor histocompatibility antigens$234,407

R21 · FY2008 · AI · contact PI

A novel method for identification of minor histocompatibility antigens$298,506

R21 · FY2007 · AI · contact PI

NOVEL VACCINE TARGETS FOR EARLY STAGE BREAST CANCER$401,066

R01 · FY2002 · CA